Key clinical point: In carefully selected patients with inflammatory bowel disease, bariatric surgery is safe and patients can experience sustained weight loss.

Major finding: The mean percentage of overall excess weight loss was 57.5% at 6 months, 63.3% at 12 months, and 58.6% at 24 months.

Study details: A retrospective study of 33 patients who underwent bariatric surgery with a preoperative or postoperative diagnosis of inflammatory bowel disease.

Disclosures: The researchers reported having no financial disclosures.